Mr. Musah, 27, who lives in Accra, the capital of Ghana, set aside dreams of starting a business, building a house, getting married. He scraped together enough cash $900, half his annual salary to buy a course of the drugs that, a decade ago, began to revolutionize hepatitis C treatment in the United States and other high-income countries.
An estimated one in 10 people, about nine million Egyptians, were chronically infected. In a public health campaign extraordinary for both its scale and its success, Egypt screened its entire population, brokered a deal for hugely discounted drugs and cured almost everyone with the virus. This is one of the greatest accomplishments ever in public health, said Dr. John W. Ward, the director of the Coalition for Global Hepatitis Elimination at the Task Force for Global Health.
[
add
]
[
|
|
...
]